The role of L-arginine in the prevention and treatment of pre-eclampsia: A systematic review of randomised trials

Journal of Human Hypertension

Volumn 28, Issue 4, 2014, Pages 230-235

  Dorniak Wall, T ^a   Grivell, R M ^a,b   Dekker, G A ^a,c   Hague, W ^a,b   Dodd, J M ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c LYELL MCEWIN HOSPITAL   (Australia)

Author keywords

hypertensive disease; L arginine; pre eclampsia; pregnancy

Indexed keywords

ARGININE;

BIBLIOGRAPHIC DATABASE; BLOOD PRESSURE; CHILD HEALTH; COMPARATIVE STUDY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL WELFARE; META ANALYSIS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL GROWTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; FEMALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTOR; TREATMENT OUTCOME; VASODILATATION; YOUNG ADULT;

ADOLESCENT; ADULT; ARGININE; BLOOD PRESSURE; FEMALE; HUMANS; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME; VASODILATION; YOUNG ADULT;

EID: 84896317926     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.100     Document Type: Review

References (35)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365(9461): 785-799.
2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33(3): 130-137.
3. López-Jaramillo P, Arenas WD, Garćia RG, Rincon MY, López M. The role of the L-arginine-nitric oxide pathway in pre-eclampsia. Ther Adv Cardiovasc Dis 2008; 2(4): 261-275.
4. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol 1994; 26: 19-33.
5. Benyó Z, Görlach C, Wahl M. Involvement of thromboxane A2 in the mediation of the contractile effect induced by inhibition of nitric oxide synthesis in isolated rat middle cerebral arteries. J Cereb Blood Flow Metab 1998; 18(6): 616-618.
6. Wang W, Diamond SL. Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun 1997; 233(3): 748-751.
7. Riddell DR, Owen JS. Nitric oxide and platelet aggregation. Vitam Horm 1999; 57: 25-48.
8. Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecher K. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the patho-physiology of preeclampsia. Gynecol Obstet Invest 2010; 69(1): 1-13.
9. Goss SP, Kalyanaraman B, Hogg N. Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation. Methods Enzymol 1999; 301: 444-453.
10. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. BJOG 1996; 103(1): 4-15.
11. McCord N, Ayuk P, McMahon M, Boyd RC, Sargent I, Redman C. System y arginine transport and NO production in peripheral blood mononuclear cells in pregnancy and preeclampsia. Hypertension 2006; 47(1): 109-115.
12. Neri I, Piccinini F, Marietta M, Facchinetti F, Volpe A. Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertens Pregnancy 2000; 19(3): 323-330.
13. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000; 4(4): 441-458.
14. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354(9193): 1896-1900.
15. Centre TNC. Review Manager (RevMan) In: Collaboration TC (ed). Copenhagen: Review Manager (RevMan), 2011.
16. Facchinetti F, Saade GR, Neri I, Pizzi C, Longo M, Volpe A. L-arginine supplementation in patients with gestational hypertension: a pilot study. Hypertens Pregnancy 2007; 26(1): 121-130.
17. Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstet Gynecol 2006; 107(4): 886-895.
18. Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in pre-eclampsia. Eur J Clin Invest 2005; 35(1): 32-37.
19. Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004; 83(1): 103-107.
20. Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011; 342: d2901.
21. Neri I, Monari F, Sgarbi L, Berardi A, Masellis G, Facchinetti F. L-arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications. J Matern Fetal Neonatal Med 2010; 23(12): 1456-1460.
22. Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J Matern Fetal Neonatal Med 2006; 19(5): 277-281.
23. Winer N, Branger B, Azria E, Tsatsaris V, Philippe HJ, Rozé JC et al. L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. Clin Nutr 2009; 28(3): 243-248.
24. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104(22): 2673-2678.
25. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99(9): 1141-1146.
26. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholester-olemic humans. J Am Coll Cardiol 1997; 29(3): 479-485.
27. Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F. Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand 1996; 75(3): 208-212.
28. Facchinetti F, Neri I, Genazzani AR. L-arginine infusion reduces preterm uterine contractions. J Perinat Med 1996; 24(3): 283-285.
29. Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS et al. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 1996; 175(4 Pt 1): 800-805.
30. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996; 174(3): 1008-1013.
31. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1998; 178(3): 551-556.
32. Pettersson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 1998; 77(8): 808-813.
33. King RG, Di Iulio JL, Gude NM, Brennecke SP. Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae. Reprod Fertil Dev 1995; 7(6): 1581-1584.
34. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dime-thylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003; 361(9368): 1511-1517.
35. Prefumo F, Thilaganathan B, Whitley GS. First-trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine. Ultrasound Obstet Gynecol 2008; 31(2): 153-157.